HYPR — Hyperfine, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1833769 ·
Last close
$0.86
Market Cap
$77.92M
52W High
$1.72
52W Low
$0.85
ADV30
673,414
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 3,904,000 | 1,980,000 | -8,469,000 | -9,298,000 | 62,999,000 | 43,458,000 | 26,241,000 |
| Mar 2026 | 3,903,000 | 1,979,000 | -8,558,000 | -8,623,000 | 60,339,000 | 40,778,000 | 25,978,000 |
| Dec 2025 | 5,293,000 | 2,694,000 | -7,668,000 | -5,912,000 | 55,262,000 | 35,085,000 | 14,257,000 |
| Sep 2025 | 3,437,000 | 1,848,000 | -8,920,000 | -11,019,000 | 41,511,000 | 21,564,000 | 14,639,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-27,065,000
Investing CF
$-465,000
Financing CF
$46,716,000
CapEx
$-465,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.38
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-347,937,000
Inventory
$6,789,000
Receivables
$5,789,000
ST Investments
—
EBIT TTM
$-33,893,000
Pretax Income TTM
$-34,852,000
Interest Exp TTM
$616,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$16,537,000
EBITDA
$-32,499,000
Free Cash Flow
$-17,161,376
Enterprise Value
$65,621,504
Total Cash
$43,458,000
Total Debt
$13,413,000
Shares Out
90,993,381
Trailing EPS
$-0.37
Book Value
$0.35
ROE
-97.0%
ROA
-38.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 13,563,000 | -37,085,000 | -35,574,000 | 55,262,000 | 14,257,000 | — | -27,948,000 |
| Dec 2024 | 12,890,000 | -43,224,000 | -40,720,000 | 58,901,000 | 9,861,000 | — | -38,767,000 |
| Dec 2023 | 11,032,000 | -48,115,000 | -44,238,000 | 94,199,000 | 9,800,000 | — | -41,809,000 |
| Dec 2022 | 6,814,000 | -73,874,000 | -73,164,000 | 134,051,000 | 10,329,000 | — | -72,339,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.32
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $1.00 · spot: $0.86 · call volume: 5 · put volume: 10
Expected Move to 2027-01-15:
±$0.70
(81.78%) —
implied range
$0.16 –
$1.56
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| OM | Outset Medical, Inc. | $78.76M | $4.19 | — |
| NRXS | Neuraxis, INC | $76.23M | $6.07 | — |
| RTGN | RetinalGenix Technologies Inc. | $75.37M | $4.00 | — |
| CVRX | CVRx, Inc. | $83.92M | $3.15 | — |
| DRIO | DarioHealth Corp. | $70.65M | $7.21 | — |
News headlines (Yahoo Finance, 1h cache)
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings
2026-08-20 12:15 · Yahoo
Hyperfine (HYPR) Q2 2026 Earnings Call Transcript
2026-08-14 00:16 · Yahoo
Hyperfine Q2 Earnings Call Highlights
2026-08-07 03:03 · Yahoo
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates
2026-08-06 23:10 · Yahoo
Hyperfine launches next-generation Swoop MRI system in Europe
2026-07-02 08:39 · Yahoo
Hyperfine shares rise after expected Russell index addition (HYPR)
2026-05-26 12:57 · Yahoo
Hyperfine, Inc. Q2 2026 Earnings Call Summary
2026-08-07 12:30 · Yahoo
Hyperfine, Inc. Reports Second Quarter 2026 Financial Results
2026-08-06 20:05 · Yahoo
Hyperfine Announces the Release of Multiple Peer-Reviewed Publications, Expanding Clinical Evidence for the Swoop® System Across a Growing Number of Sites of Care
2026-07-30 12:15 · Yahoo
Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026
2026-07-23 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.